T. Rowe Price Associates’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
|
|||||
|
2025
Q1 | $475K | Buy |
|
|||||
|
2024
Q4 | $468K | Buy |
|
|||||
|
2024
Q3 | $321K | Sell |
|
|||||
|
2024
Q2 | $261K | Buy |
|
|||||
|
2024
Q1 | $196K | Buy |
|
|||||
|
2023
Q4 | $305K | Buy |
|
|||||
|
2023
Q3 | $237K | Buy |
|
|||||
|
2023
Q2 | $266K | Buy |
|
|||||
|
2023
Q1 | $285K | Buy |
|
|||||
|
2022
Q4 | $99K | Buy |
|
|||||
|
2022
Q3 | $162K | Buy |
|
|||||
|
2022
Q2 | $129K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $5.51M | Buy |
|